Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Protein phosphatase regulation by endogenous inhibitors.

Shenolikar S.

Semin Cancer Biol. 1995 Aug;6(4):219-27. Review.

PMID:
8541517
2.

Physiologic importance of protein phosphatase inhibitors.

Oliver CJ, Shenolikar S.

Front Biosci. 1998 Sep 1;3:D961-72. Review.

PMID:
9727084
3.

Phosphorylation of protein phosphatase-1 inhibitors, inhibitor-1 and DARPP-32, in renal medulla.

Higuchi E, Nishi A, Higashi H, Ito Y, Kato H.

Eur J Pharmacol. 2000 Nov 17;408(2):107-16.

PMID:
11080516
4.

Broad specificity in binding of NIPP-1, nuclear inhibitor of protein phosphatase-1, to PP1 isoforms in vivo.

Kim SE, Shima H, Nakamura K, Kikuchi K.

Tohoku J Exp Med. 2000 May;191(1):39-45.

5.

Inactivation of nuclear inhibitory polypeptides of protein phosphatase-1 (NIPP-1) by protein kinase A.

Beullens M, Van Eynde A, Bollen M, Stalmans W.

J Biol Chem. 1993 Jun 25;268(18):13172-7.

6.

Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor.

Endo S, Zhou X, Connor J, Wang B, Shenolikar S.

Biochemistry. 1996 Apr 23;35(16):5220-8.

PMID:
8611507
7.

Inhibitors of protein phosphatase-2A: topography and subcellular localization.

Tanimukai H, Grundke-Iqbal I, Iqbal K.

Brain Res Mol Brain Res. 2004 Jul 26;126(2):146-56.

PMID:
15249138
8.

Nuclear organisation of NIPP1, a regulatory subunit of protein phosphatase 1 that associates with pre-mRNA splicing factors.

Trinkle-Mulcahy L, Ajuh P, Prescott A, Claverie-Martin F, Cohen S, Lamond AI, Cohen P.

J Cell Sci. 1999 Jan;112 ( Pt 2):157-68.

9.

DARPP-32 and inhibitor-1 are expressed in pancreatic beta-cells.

Lilja L, Meister B, Berggren PO, Bark C.

Biochem Biophys Res Commun. 2005 Apr 8;329(2):673-7.

PMID:
15737638
11.

D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade.

Flores-Hernandez J, Hernandez S, Snyder GL, Yan Z, Fienberg AA, Moss SJ, Greengard P, Surmeier DJ.

J Neurophysiol. 2000 May;83(5):2996-3004.

12.

[Regulatory proteins of type 1 protein phosphatase].

Kotani H, Ito M, Ichikawa K, Nakano T.

Tanpakushitsu Kakusan Koso. 1998 Jun;43(8 Suppl):1072-82. Review. Japanese. No abstract available.

PMID:
9655965
13.

Conversion of protein phosphatase 1 catalytic subunit to a Mn(2+)-dependent enzyme impairs its regulation by inhibitor 1.

Endo S, Connor JH, Forney B, Zhang L, Ingebritsen TS, Lee EY, Shenolikar S.

Biochemistry. 1997 Jun 10;36(23):6986-92.

PMID:
9188695
14.

Complementary distribution of the phosphoproteins DARPP-32 and I-1 in the cerebellar system.

Alder R, Barbas H.

Neuroreport. 1995 Nov 27;6(17):2368-72.

PMID:
8747155
15.

Molecular determinants of nuclear protein phosphatase-1 regulation by NIPP-1.

Beullens M, Van Eynde A, Vulsteke V, Connor J, Shenolikar S, Stalmans W, Bollen M.

J Biol Chem. 1999 May 14;274(20):14053-61.

16.

Properties and phosphorylation sites of baculovirus-expressed nuclear inhibitor of protein phosphatase-1 (NIPP-1).

Vulsteke V, Beullens M, Waelkens E, Stalmans W, Bollen M.

J Biol Chem. 1997 Dec 26;272(52):32972-8.

17.

Families of protein phosphatase 1 modulators activated by protein kinases a and C: focus on brain.

Liu QR, Gong JP, Uhl GR.

Prog Nucleic Acid Res Mol Biol. 2005;79:371-404. Review. No abstract available.

PMID:
16096033
18.

1H, 15N, and 13C resonance assignments of DARPP-32 (dopamine and cAMP-regulated phosphoprotein, Mr. 32,000)--a protein inhibitor of protein phosphatase-1.

Lin TH, Huang YC, Chin ML, Chen YC, Jeng HH, Lin FM, Shiao MS, Horiuchi A, Greengard P, Nairn AC, Huang HB.

J Biomol NMR. 2004 Apr;28(4):413-4. No abstract available.

PMID:
14872138
19.
20.

Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP.

Blitzer RD, Connor JH, Brown GP, Wong T, Shenolikar S, Iyengar R, Landau EM.

Science. 1998 Jun 19;280(5371):1940-2.

Supplemental Content

Support Center